MAA Ibrahim, AHM Abdelrahman, LA Jaragh Alhadad…
Pharmaceuticals (Basel). 2022 Jan 27;15(2):153.
Science Published: (Jan/2022)
DOI: https://doi.org/10.3390/ph15020153
Abstract:
The main protease (Mpro) is a potential druggable target in SARS-CoV-2 replication. Herein, an in silico study was conducted to mine for Mpro inhibitors from toxin sources. A toxin and toxin-target database (T3DB) was virtually screened for inhibitor activity towards the Mpro enzyme utilizing molecular docking calculations. Promising toxins were subsequently characterized using a combination of molecular dynamics (MD) simulations and molecular mechanics-generalized Born surface area (MM •
